[1]
C. Santipanichwong and P. Pongcharoen, “Unmasking Silent Lipomatosis: A Reversible Adverse effect of PPAR-γ Agonist Therapy”, Thai J Dermatol, vol. 42, no. 3, pp. 70–73, Jul. 2026.